Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
13th International Conference on AD/PD
jun 2017 | Bewegingsstoornissen, Dementie